MedElevator Войти в исследования
← Поиск публикаций

DOI 10.3389/fphar.2022.936659

Медицинская библиотека · Frontiers in pharmacology · 2022

Apolipoprotein-A-I for severe COVID-19-induced hyperinflammatory states: A prospective case study.

Faguer Stanislas, Del Bello Arnaud, Danet Chloé, Renaudineau Yves, Izopet Jacques, Kamar Nassim

СтатьяПеревод пока не подготовлен

Аннотация

BACKGROUND Thyroglossal duct cysts are the most common congenital cervical anomalies, often presenting as midline neck cysts. The mean age of presentation of pediatric thyroglossal duct cysts varies between 5 and 9 years old, with rare cases younger than 1 year old. This case report details a rare case of an infected thyroglossal duct cyst presenting during the neonatal period as an upper airway obstruction. CASE REPORT A 3-week-old neonate born full-term with no complications during pregnancy or labor presented with a 5-day history of worsening nasal congestion and upper airway obstruction after an upper respiratory infection. Physical examination revealed a large midline neck mass measuring 3.1×4.2×3.2 cm abutting the hyoid with internal echogenicity consistent with a thyroglossal duct cyst, causing posterior tongue compression of the airway and airway distress. The patient was emergently taken to the operating room for incision and drainage, where she underwent a difficult intubation due to superior-posterior tongue displacement and global supraglottic edema. She was discharged on postoperative day 5 on a course of Augmentin after cultures grew methicillin-sensitive Staphylococcus aureus. The patient had no further complications, with successful excision using a Sistrunk procedure 6 months later. CONCLUSIONS Pediatric thyroglossal duct cysts most often present as an asymptomatic midline neck mass, with rare sequelae of infection and upper airway obstruction. This case report highlights the pathophysiology and presenting symptomology of thyroglossal duct cysts, explores the rarity of infected thyroglossal duct cysts in neonates, and reviews the current literature on management strategies for these patients.

Для цитирования: Faguer Stanislas, Del Bello Arnaud, Danet Chloé, Renaudineau Yves, Izopet Jacques, Kamar Nassim. Apolipoprotein-A-I for severe COVID-19-induced hyperinflammatory states: A prospective case study.. Frontiers in pharmacology. 2022. DOI: 10.3389/fphar.2022.936659.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.